By Dr Nahla Madan NCD Committee April 2010. The working group on the guideline The working Group Reviewing Group Dr. Ibtihal Al Reefy Dr. Badryia Yaser.

Slides:



Advertisements
Similar presentations
This short questionnaire will help to determine whether there may be a gene in your family connected to an increased risk of the development of bowel.
Advertisements

New Hampshire Colorectal Cancer Screening Program (NHCRCSP) and “DRESS IN BLUE DAY” State of New Hampshire - Wellness Coordinators Susan Kuhn,
What is your diagnosis now? Other considerations? Bases?
This grey area will not appear in your presentation. Fighting back Against Colon Cancer Presentations prepared by: Canadian Cancer Society, Ontario Division,
March is COLORECTAL CANCER AWARENESS Month
1 Colorectal Cancer and Screening Cancer Screening Programs September 2013.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Colon Cancer Are You at Risk? Colorectal Cancer: What Is It?
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
What Everyone Should Know About Colon Cancer Prevention Maria T. Abreu, MD Chief, Division of Gastroenterology Professor of Medicine.
Colorectal Cancer & Screening Sept Sometimes there are things that may be hard to talk about… But not talking about them is even harder.
Introduction Presentation Overview I.What is colon cancer? II.Reduce your risk III. How to find a screening facility IV. Patient resources V.Get involved.
Colorectal Cancer Update Jonathan A. Laryea, MD FACS FASCRS FWACS Division of Colon & Rectal Surgery Department of Surgery University of Arkansas for Medical.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Y o u r C o u n t y C r u s a d e A g a in s t C a n c e r.

Colorectal Cancer Overview
Mobilizing Newcomers and Immigrants to Cancer Screening Programs Funded by Public Health Agency of Canada (PHAC) The views expressed herein do not necessarily.
Bowel Cancer Awareness Claire Stephenson Health Promotion & Outreach Coordinator.
Screening and Early Diagnosis of Colorectal Cancer
 2 nd overall leading cause of cancer death in the United States › 3 rd in each sex  Approximately 6% of individuals in the US will develop a cancer.
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Colon-Rectal Cancer Keith Bradley, MD National Alliance of Research Associates Programs NARAP.
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Integrated Cancer Screening Colorectal Cancer Screening.
Intervention for Prevention Marigo Werner  Define colon cancer  Discuss pathophysiology of colon cancer  Discuss morbidity and mortality statistics.
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
Better Health. No Hassles. Colon Cancer Cancer of the large intestine 112,000 people are diagnosed annually 41,000 new cases of rectal cancer annually.
D. M. Kruss MD Kill the Cancer Do Screening now! Daniel M. Kruss, M.D. Kill the Cancer Do Screening now! Daniel M. Kruss, M.D.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colon Cancer First Page.
Interventions for Clients with Colorectal Cancer
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Prevention and Health Promotion Administration May Overview of Colorectal Cancer Maryland Department of Health & Mental Hygiene Prevention and Health.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
COLORECTAL CANCER Ozlem Uysal-Sonmez, MD Yeditepe University Hospital Department of Medical Oncology.
Better Health. No Hassles. Colorectal Cancer Facts – The 2 nd leading cause cancer-related deaths in the Nation – Highly preventable – Caused 49,920 deaths.
Pathology Report Colorectal Cancer Sahar Najibi April 11 th, 2008.
Cancer Prevention Eyad Alsaeed, MD,FRCPC Consultant Radiation Oncology PSHOC KFMC.
ACCESSORY DIGESTIVE ORGANS LIVER GALLBLADDER PANCREAS.
Colorectal Cancer Proposal of a Screening Program for Developing Countries with Emphasis on Costs.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
By: Stella Amoah, BSN, RN.  What is Cancer of the colon & rectum  Abdominal Organs  Causes of Colon Cancer  Symptoms  How to Detect Colon Cancer.
Definition Signs & symptoms Treatment Root of the disease.
Dr M E Donat Center for Digestive Health (248) Sunday May
Interventions for Clients with Colorectal Cancer.
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
Dr. Harman Dhaliwal Sleepy Eye Medical Center Women’s Expo – September 28, 2013.
A Pharmacy Based Bowel Cancer Screening Program. Did You Know? Bowel cancer kills more Australians each year than breast or prostate cancer (AIHW 2012.
D. M. Kruss MD Colon Cancer How to nip it in the bud! Daniel M. Kruss, M.D. Colon Cancer How to nip it in the bud! Daniel M. Kruss, M.D.
Immunochemical Fecal Occult Blood Testing
Colon Cancer The Bottom Line
What Everyone Should Know About Colon Cancer Prevention
Colorectal Cancer: Risk Prevention and Diagnosis
Different Tests to Detect Colonic Polyps
27th Annual Winter CME Conference
Cancer Can Not Comfort But Your Family Can
More Ontarians need to be screened for colorectal cancer (Sept. 2012)
Colorectal Cancer Screening
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
Module 4: Colorectal Cancer
Colorectal Cancer.
When cancer develops in the cells lining the colon.
Inflammatory Bowel Disease (IBD)
Supporting Patients With Colorectal Cancer
Colon Doctor San Antonio
Presentation transcript:

By Dr Nahla Madan NCD Committee April 2010

The working group on the guideline The working Group Reviewing Group Dr. Ibtihal Al Reefy Dr. Badryia Yaser Dr. Fathyia Abdulla Dr. Mai Bubshait Dr. Basma Al Tajer Dr. A. Hussain AL Ajami Dr. Mariam Al-Jalahma Dr. Kadhim Jaffer Zaber Dr. Ali Mirza Salman Dr. Abeer Al Ghawi

Colorectal cancer facts Majority of colorectal cancer develop from precancerous changes (polyps) About 90% of patients are over the age of 50 Early Colorectal cancers are usually asymptomatic The average duration of symptoms (from onset to diagnosis) is 14 weeks. There is no association between overall duration of symptoms and the stage of the tumor

Symptoms of Colorectal Cancer :May Includes Constipation/Diarrhea Narrow Stools Abdominal Cramps Bloody Stools Unexplained Weight Loss/Loss of Appetite Sense of Fullness Nausea & Vomiting Gas & Bloating Lethargy (Fatigue)

Colorectal cancer Risk factors Age >50 Personal or family history of colorectal cancer or adenomatous polyp Familial syndromes as Familial Adenomatous Polyposis (FAP) or Hereditary Non-polyposis Colorectal Cancer (HNPCC) H/o inflammatory bowel diseases High animal fat diet Tobacco Physical inactivity

Colorectal screening guidelines in PHC For average risk population Screening starts at the age of or until there is a 30% chance of living to the next screening interval

Colorectal screening guidelines in PHC For average risk population Fecal Occult Blood Test (FOBT) annually and Flexible Sigmoidoscopy every 5 years Colonoscopy every 10 years or

Colorectal screening guidelines in PHC For High risk population Screening start at the age of 40 or 10 years before the age of cancer in the first degree relative First degree relative: Any relative who is one meiosis away from a particular individual in a family (i.e., parent, sibling, offspring)

Colorectal screening guidelines in PHC For special risk population Patients with hereditary colorectal cancer syndrome should undergo annual colonoscopy Patients with Ulcerative Colitis or Crohns Colitis of 7-10 years duration should start colonoscopy screening every 1-3 years

Colorectal Screening tests Colonoscopy is the most sensitive and specific test of the all available screening tests of colorectal cancer FOBT has the most direct evidence of reducing colorectal cancer mortality The sensitivity of sigmoidoscopy as a screening tests affected by type of the instrument

What is available in PHC A pilot screening campaign will be started using HEXAGON OBTI to test stool for human blood in all adult years of age attending LHC The available test sample for the pilot campaign is 500, and will be distributed in the following HC: Muharraq HC Shaikh Sabah HC Aali HC East Raffa HC

Pilot screening campaign for colorectal cancer The pilot period will end by using all the test samples It is necessary to collect data about the tested candidates for the future analysis and updating of the guidelines Collecting data will be by a form filled by the referring physician After the pilot campaign, guidelines of colorectal cancer screening will be updating and a second awareness session will follow

HEXAGON OBTI Immunochromatographic rapid test This rapid screening test detects human blood in the stool. HEXAGON OBTI is a two- part test: - Collection tube for the blood sample - Test bar

Directions Unscrew the cap of the tube and collect the sample with the applicator stick by taking several postions at different sites (3-4) of the faeces. Remove excess stool with a tissue. Reinsert the applicator stick into the tube. This sample collected is stable at room temperature and must be tested within one week after collection. With the lid screwed back on, shake the sample gently inside the transport medium to assure proper mixing.

Directions Hold the tube with the red end upwards and break-off the tip. Dispense exactly 2 full drops, drop by drop, into the test in the sample well (S) at the lower end of the test.

Results A positive sample is typically detected within 2-3 minutes. Negative results should be confirmed after 10 minutes.

Interpretation of Results A single blue line means the testing liquid is working fine, but no human blood has been detected. It is called a control line Two blue lines mean the test has detected human blood (even if blue color is weak) No control line means that the test should be repeated

Positive NegativeInvalid

Other features The test kit is stable up to the given expiration date when stored at 2 – 25 o C Dietary restrictions are not necessary

Thank You and hope you a good day